BioNano Genomics Gets $53M

San Diego-based BioNano Genomics said this morning that it has raised $53M in a Series C funding round, for the company's genome mapping technology. The funding was co-led by Legend Capital and Novartis Venture Fund, and also included Federated Kaufmann Fund and Monashee Investment Management, along with Domain Associates, Battelle Ventures and Gund Investment Corporation. Darren Cai of Legend Capital and Campbell Murray of Novartis join the company's board as partof the funding. More information »